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Introduction
Biological monitoring is generally described as the planned and repeated collection of specimens of tissue or body fluid, for the purpose of estimating the chemical composition of the body's internal environment. The repeated aspect differentiates monitoring from sampling and emphasizes the point that temporal changes in chemical composition are just as important as the estimates at a single time.
Motivations for biological monitoring arise in clinical medicine, forensic toxicology, and occupational hygiene. Medical applications include the repeated sampling of peripheral blood to assess the circulating level of a therapeutic drug given as a means of treating a diagnosed illness. The biological monitoring data provide the information necessary to adjust the dosing regimen to account for the individual characteristics of the patient and to achieve the desired effect without overexposure. The major application of biological monitoring in forensic toxicology is the periodic sampling of voided urine of workers in certain critical jobs, followed by analysis for evidence of use of incapacitating or illegal drugs or other substances. It should be noted that the collection of a breath sample by a traffic officer who suspects a driver of ethanol intoxication would fit the description of biological sampling but not monitoring. In occupational hygiene, biological monitoring is used as part of an array of techniques for evaluating the worker's risk of health damage due to exposure to chemical agents and it is especially valuable when conducted to indicate exposure to a potentially harmful chemical at a time when preventive measures can be effective in reducing or eliminating the health risk.
Occupational biological monitoring must be viewed as complementary to, and not a replacement for, the more traditional measurement of airborne concentrations of chemical agents (1) . It provides additional information that can be of great value in evaluating and controlling risky exposures.
The advantages offered by biological monitoring in the occupational setting have been thoroughly reviewed by others (2-4) and will not be explored here in any detail. This form of exposure monitoring invokes some additional requirements, however, one of which is the existence of reference values against which observed biological concentrations may be compared to form judgments about the acceptability of the workplace conditions.
One substantial collection of reference values for biological monitoring in workplaces is the list of Biological Exposure Indices (BEI) published by the American Conference of Governmental Industrial Hygienists (ACGIH). Organizations such as the ACGIH, together with governmental regulating agencies, perform a key role at the interface between science and policy; ideally, their mission is to use the best available scientific and technical data to set recommended or regulatory limits that will minimize the health risks to workers while maximizing the benefit to society of the economic activity associated with the work.
This review describes the BEI in terms of the philosophy and process under which they are established and the role they play in the practice of occupational hygiene and occupational medicine. The extent to which the BEI meet the expectations of the scientific, regulatory, and practitioner communities will be addressed and their strengths and limitations will be explored. The pace of scientific development offers the opportunity to speculate on directions to be taken in generating or revising the BEI and other reference values for biological monitoring over the next decade.
Defining Characteristics of the Biological Exposure Indices
The BEI are reference values intended as guidelines for the evaluation of potential health hazards in the practice of industrial hygiene (5) . The mission of industrial hygiene is the anticipation, recognition, evaluation, and control of exposure to health hazards in the workplace, with the overall aim of preventing or minimizing adverse health effects of exposure. Thus, when the BEI are used by physicians, nurses, engineers, or industrial hygienists, their principal application should be to support prevention of injurious exposures.
These reference values are the recommendations of a professional society, the Table 1 .
A proposed BEI is supported by a document that reviews the scientific data used in developing the reference value and that contains a synoptic rationale for the recommendation. The documentation must conform to a standard format incorporating relevant physical and chemical properties of the chemical; toxicokinetic data; discussion of possible nonoccupational exposure; the value and rationale for the corresponding TLV; a discussion of sampling and analytical methods for the determinant(s); anticipated biological levels without occupational exposure; the timing of appearance of the determinant; factors affecting interpretation of the measurement; the justification for the recommended BEI together with a critical assessment of the current data available; and finally, a description of (5) published annually by the ACGIH containing the adopted and proposed values for all TLV and BEI and is a formal invitation for comment and criticism from all interested parties. Annual circulation of the booklet is over 100,000 copies worldwide. (20) .
Clinical effects on renal function, bone marrow, and central nervous system are associated with blood lead levels of 50 jig/dl and higher (12 (34, 37, 38) . Since the goal is prevention, the industrial hygienist will be most interested in a biological indicator that reveals the effectiveness of control measures adopted after a judgment of hazardous exposure has been reached. If the indicator is irreversible, its appearance will alert the hygienist to a potentially hazardous situation but will not provide evidence that mitigating measures are working. (41) . In some cases these adducts can be shown to be specific to an environmental agent or group of agents, but in other cases the adducts are not specific (37) . In addition, there remain questions about the relationship of adducts appearing in peripheral blood to genetic damage presumed to occur within the target cells (40, 42) .
Chromosomal Aberrations, Sister Chromatid Exchange, and Micronuclei. Structural changes in chromosomes and other microscopic evidence of damage to chromosomes, including the appearance of micronuclei are also possible candidates for occupational biological monitoring methods. This form of monitoring is most often classified as indicating altered structure or function and occasionally as an indicator of early biological effect. In either event, the reversibility of the marker is an important characteristic that will influence its role in the development of BEI values. Insufficient data presently exist concerning the sensitivity and specificity of these assays at levels of exposure encountered in the workplace (43) .
Genetic Markers ofExposure and Suseeptibility. Another developing area of macromolecular biology is the analysis of genetic material as an indicator of the activity or inducibility of enzymes in an individual (37) . The variation in activity of enzymes mediating phase I and phase II metabolism of absorbed chemicals will affect individual response to exposure in a manner that can be predicted. Expression of enzyme activity is under genetic control, as is the response of enzyme activity to environmental exposures to the substrate itself or to other chemicals (42 (45) . Further, should a worker be identified to be at elevated risk due to personal biological factors such as hereditary variation in metabolizing capability or environmentally induced change in toxicokinetic processes, there is not commonly a policy in place for fair treatment: financial coverage for medical removal or job transfer is seldom planned for by the employer.
The principle of confidentiality of medical records has at times interfered with the use of biological monitoring data by industrial hygienists. In keeping with the goal of preventing or minimizing exposure, the industrial hygienist must have access to such data to conduct a complete exposure assessment; at the same time, workers' rights to confidentiality should be maintained and the management scheme for accomplishing these often contradictory goals must be developed carefully in advance.
Scientific Impediments: Variation and Background Several technical and scientific issues pose obstacles to widespread use of biological monitoring and BEI in industrial settings where they could provide valuable information (34) . These include matters of ambiguity in interpretation of the BEI and the consequences of the general decline in exposure levels in most industries with time.
Variability over time in biological levels of an indicator within an individual and between workers at the same time must arise when the environmental concentrations fluctuate. However, variation in toxicokinetics both within and between workers also contributes and this component can dominate the observed variability (46, 47) . This poses substantial difficulty in interpreting a single biological monitoring result by comparison to the BEI: if the result exceeds the BEI, is this evidence for a hazardous exposure? The BEI Committee has taken a general approach to this issue by advising that due to biological variability it is possible for an individual's measurement to exceed the BEI without incurring an increased health risk. If, however, measurements in specimens obtained from a worker on different occasions persistently exceed the BEI or if the majority of workers at the same workplace exceed the BEI, the cause of the excessive values must be investigated and control measures must be implemented. This suggests that in some instances the group mean rather than the individual values should be compared to the BEI and that serial measurements may be necessary. Present data concerning individual variability are not sufficient to place more precise limits on the acceptable range of values about the BEI. However, some techniques have been described recently for predicting the expected distribution of biological levels among normal workers with realistic variation in toxicokinetic parameters (48, 49) . As these techniques become refined, it should be possible to specify the BEI as a reference distribution (37, 50) (51) . Studies of the expression of mRNA in chemically exposed populations are in progress and may lead to a powerful method for individual biological monitoring of exposure.
One of the major factors determining individual differences in susceptibility to chemical exposure is variation in metabolic handling of solvents and other agents (33) . The existence of genetically determined bimodal or multimodal distributions of metabolizing capability in humans has been known for some time (52) . For example, the ability to oxidize debrisoquine, mediated by one of the cytochrome P450 isoenzymes, shows a bimodal distribution in the Caucasian population and this genetic dimorphism is associated with similar differences in rates of metabolism of certain industrial chemicals (53) . There is a similar genetic polymorphism in the rate of conjugation of metabolites mediated by N-acetyltransferase (42 (58) . That trend could relieve some of the concern over the risk and benefit balance for clinical experimentation in this area.
For biological markers of early response and susceptibility, an additional ethical concern has been articulated (59) . For example, if in an epidemiological study of a biomarker of effect aimed at determining its prevalence and reliability as a function of exposure, early on its prevalence is elevated in certain workers, it may be very difficult to complete the study: the employer may wish to modify the working conditions to lower exposures on the basis of early appearance of a biomarker that could be associated with health risk. While this decision would be fully defensible in view of the desire to prevent adverse health outcomes, it could be devastating to the research design. Epidemiologists pursuing data that are essential to the validation of biological markers in exposed working populations must be prepared to deal with this problem.
Access to worker populations for epidemiologic research is also constrained to some extent by the need to plan for possible compensation costs should workers in the study reveal (6, 7, 61) . In many cases the reference values are similar, but there are significant differences in both the approach to setting biological reference values and in their interpretation (38) . For example, the BAT are established as maximum tolerable levels (40); in Japan, the values are specified according to a reference distribution with three levels (62) 
